CVE-2011-1213

Description

Integer underflow in lzhsr.dll in Autonomy KeyView, as used in IBM Lotus Notes before 8.5.2 FP3, allows remote attackers to execute arbitrary code via a crafted header in a .lzh attachment that triggers a stack-based buffer overflow, aka SPR PRAD88MJ2W.

Category

9.3
CVSS
Severity: Critical
CVSS 2.0 •
EPSS 81.77% Top 5%
Vendor Advisory secunia.com
Affected: n/a n/a
Published at:
Updated at:

References

Link Tags
http://www.ibm.com/support/docview.wss?uid=swg21500034
http://www.securityfocus.com/bid/47962 vdb entry
http://labs.idefense.com/intelligence/vulnerabilities/display.php?id=904 third party advisory
http://secunia.com/advisories/44624 third party advisory vendor advisory
https://exchange.xforce.ibmcloud.com/vulnerabilities/67620 vdb entry
https://oval.cisecurity.org/repository/search/definition/oval%3Aorg.mitre.oval%3Adef%3A14634 vdb entry signature
http://securityreason.com/securityalert/8285 third party advisory

Frequently Asked Questions

What is the severity of CVE-2011-1213?
CVE-2011-1213 has been scored as a critical severity vulnerability.
How to fix CVE-2011-1213?
To fix CVE-2011-1213, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2011-1213 being actively exploited in the wild?
It is possible that CVE-2011-1213 is being exploited or will be exploited in a near future based on public information. According to its EPSS score, there is a ~82% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.